Muul LM - Search Results

1

Tpl2 kinase regulates T cell interferon-gamma production and host resistance to Toxoplasma gondii.

Watford WT, Hissong BD, Durant LR, Yamane H, Muul LM, Kanno Y, Tato CM, Ramos HL, Berger AE, Mielke L, Pesu M, Solomon B, Frucht DM, Paul WE, Sher A, Jankovic D, Tsichlis PN, O'Shea JJ. Watford WT, et al. Among authors: muul lm. J Exp Med. 2008 Nov 24;205(12):2803-12. doi: 10.1084/jem.20081461. Epub 2008 Nov 10. J Exp Med. 2008. PMID: 19001140 Free PMC article.

2

Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4.

Watford WT, Hissong BD, Bream JH, Kanno Y, Muul L, O'Shea JJ. Watford WT, et al. Immunol Rev. 2004 Dec;202:139-56. doi: 10.1111/j.0105-2896.2004.00211.x. Immunol Rev. 2004. PMID: 15546391 Review.

3

Proprotein convertase furin is preferentially expressed in T helper 1 cells and regulates interferon gamma.

Pesu M, Muul L, Kanno Y, O'Shea JJ. Pesu M, et al. Blood. 2006 Aug 1;108(3):983-5. doi: 10.1182/blood-2005-09-3824. Epub 2006 Apr 20. Blood. 2006. PMID: 16627761 Free PMC article.

4

Distinct regulation of interleukin-17 in human T helper lymphocytes.

Chen Z, Tato CM, Muul L, Laurence A, O'Shea JJ. Chen Z, et al. Arthritis Rheum. 2007 Sep;56(9):2936-46. doi: 10.1002/art.22866. Arthritis Rheum. 2007. PMID: 17763419 Free PMC article.

5

Unexpected and variable phenotypes in a family with JAK3 deficiency.

Frucht DM, Gadina M, Jagadeesh GJ, Aksentijevich I, Takada K, Bleesing JJ, Nelson J, Muul LM, Perham G, Morgan G, Gerritsen EJ, Schumacher RF, Mella P, Veys PA, Fleisher TA, Kaminski ER, Notarangelo LD, O'Shea JJ, Candotti F. Frucht DM, et al. Among authors: muul lm. Genes Immun. 2001 Dec;2(8):422-32. doi: 10.1038/sj.gene.6363802. Genes Immun. 2001. PMID: 11781709

6

Peripheral expansion of pre-existing mature T cells is an important means of CD4+ T-cell regeneration HIV-infected adults.

Walker RE, Carter CS, Muul L, Natarajan V, Herpin BR, Leitman SF, Klein HG, Mullen CA, Metcalf JA, Baseler M, Falloon J, Davey RT Jr, Kovacs JA, Polis MA, Masur H, Blaese RM, Lane HC. Walker RE, et al. Nat Med. 1998 Jul;4(7):852-6. doi: 10.1038/nm0798-852. Nat Med. 1998. PMID: 9662381

7

Flow cytometry analysis of adenosine deaminase (ADA) expression: a simple and reliable tool for the assessment of ADA-deficient patients before and after gene therapy.

Otsu M, Hershfield MS, Tuschong LM, Muul LM, Onodera M, Ariga T, Sakiyama Y, Candotti F. Otsu M, et al. Among authors: muul lm. Hum Gene Ther. 2002 Feb 10;13(3):425-32. doi: 10.1089/10430340252792558. Hum Gene Ther. 2002. PMID: 11860709

8

Immune responses to gene-modified T cells.

Muul LM, Candotti F. Muul LM, et al. Curr Gene Ther. 2007 Oct;7(5):361-8. doi: 10.2174/156652307782151489. Curr Gene Ther. 2007. PMID: 17979682 Review.

9

Persistence and expression of the adenosine deaminase gene for 12 years and immune reaction to gene transfer components: long-term results of the first clinical gene therapy trial.

Muul LM, Tuschong LM, Soenen SL, Jagadeesh GJ, Ramsey WJ, Long Z, Carter CS, Garabedian EK, Alleyne M, Brown M, Bernstein W, Schurman SH, Fleisher TA, Leitman SF, Dunbar CE, Blaese RM, Candotti F. Muul LM, et al. Blood. 2003 Apr 1;101(7):2563-9. doi: 10.1182/blood-2002-09-2800. Epub 2002 Nov 27. Blood. 2003. PMID: 12456496 Free article. Clinical Trial.

10

Immune response to fetal calf serum by two adenosine deaminase-deficient patients after T cell gene therapy.

Tuschong L, Soenen SL, Blaese RM, Candotti F, Muul LM. Tuschong L, et al. Among authors: muul lm. Hum Gene Ther. 2002 Sep 1;13(13):1605-10. doi: 10.1089/10430340260201699. Hum Gene Ther. 2002. PMID: 12228015

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47 results

Search Page